During the past decade, Iowa Methodist Medical Center conducted 180 clinical trials. In the 10-year time frame, 180 clinical trials started and 137 clinical trials were completed, i.e. on average, 76.1% percent of trials that started reached the finish line to date. In the past 5 years, 85 clinical trials started and 67 clinical trials were completed. i.e. 78.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Iowa Methodist Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 159 trials, followed by "Alliance for Clinical Trials in Oncology" with 41 trials sponsored, "SWOG Cancer Research Network" with 31 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "NRG Oncology" with 21 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Iowa Methodist Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 154 trials as a collaborator, "NRG Oncology" with 46 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 9 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Iowa Methodist Medical Center" are "Recurrent Ovarian Carcinoma" (18 trials), "Recurrent Fallopian Tube Carcinoma" (14 trials), "Recurrent Primary Peritoneal Carcinoma" (13 trials), "Recurrent Breast Carcinoma" (12 trials) and "Fallopian Tube Transitional Cell Carcinoma" (10 trials). Many other conditions were trialed in "Iowa Methodist Medical Center" in a lesser frequency.

Most popular intervention types in "Iowa Methodist Medical Center" are "Drug" (252 trials), "Other" (204 trials), "Biological" (118 trials), "Procedure" (77 trials) and "Radiation" (73 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (104 trials), "Quality-of-Life Assessment" (85 trials), "Questionnaire Administration" (57 trials), "Paclitaxel" (45 trials) and "Carboplatin" (35 trials). Other intervention names were less common.

The vast majority of trials in "Iowa Methodist Medical Center" are 239 trials for "All" genders, 68 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are NaN active trials in "Iowa Methodist Medical Center". undefined are not yet recruiting, 85 are recruiting, 118 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 88 completed trials in Iowa Methodist Medical Center, 7 suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Iowa Methodist Medical Center, 13 "Phase 1" clinical trials were conducted, 148 "Phase 2" clinical trials and 160 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".

Iowa Methodist Medical Center has several departments that took part in Clinical trials: "Medical Oncology and Hematology Associates at John Stoddard Cancer Center" - 129 trials, "John Stoddard Cancer Center at Iowa Methodist Medical Center" - 159 trials, "Wendt Regional Cancer Center of Finley Hospital" - 57 trials, "Powell Chemical Dependency Center" - 5 trials